Advanced Wound Care Market size valued at USD 10.46 billion in 2021 and expected to reach USD 15.52 billion by 2028, at a CAGR of 5.8% during the forecast period 2022-2028. Advanced wound care consists of products which are used for the treatment of acute & chronic wounds like burns, ulcers, post-operative wounds etc. Advanced wound care products like foam and film dressings, hydrocolloids hydrogels, and alginates are used to hydrate the wound and encourage healing without blocking wound. Advanced Wound care market offers various solutions for patients who are suffering from chronic wounds, by providing easily accessible and economical products. The advanced wound care market consists a group of competing technologies like hyperbaric oxygen therapy devices, advanced technologies in wound dressing, biologics/bioactive products, and Negative Pressure Wound Therapies (NPWT). As the technology becomes progressive and viable, it improves quality of life of the patients. Conventional wound care products are being substituted by the advanced wound care products owing to their effectiveness and efficacy in the management of wounds by enabling speedy healing.
In June 2015, Oculus Innovative Sciences received 510(k) clearance from U.S. FDA for Alevicyn SG Antipruritic Spray Gel for the treatment of dermatological conditions like lacerations, itching and burning of skin, skin irritation, abrasions
In May 2013, TriStar Wellness Solutions, Inc. signed a 3 year exclusive licensing agreement with Polytherapeutics, Inc. for PharmaDur drug delivery technology, for over-the-counter (“OTC”) products for treatment of wound care applications
In April 2016, Integra Life and Vomaris Wound Care, Inc. entered into an agreement for the advanced wound care market
In January 2016, the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) received USFDA approval for treatment of certain diabetic foot ulcers